BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 22790128)

  • 1. A case of IgG4-related sclerosing cholangitis overlapped with primary biliary cirrhosis.
    Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Shimizu S; Kondo H; Yoshida M; Yamashita H; Nojiri S; Takahashi S; Joh T
    Intern Med; 2012; 51(13):1695-9. PubMed ID: 22790128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overlap of IgG4-related sclerosing cholangitis and primary biliary cirrhosis.
    Takemoto R; Miyake Y; Harada K; Nakanuma Y; Moriya A; Ando M; Hirohata M; Yamamoto K
    Intern Med; 2014; 53(13):1429-33. PubMed ID: 24990335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.
    Koyabu M; Uchida K; Miyoshi H; Sakaguchi Y; Fukui T; Ikeda H; Takaoka M; Hirohara J; Nishio A; Uemura Y; Uemoto S; Okazaki K
    J Gastroenterol; 2010 Jul; 45(7):732-41. PubMed ID: 20087609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].
    Stiehl A
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis: a new overlap of autoimmune liver diseases.
    Burak KW; Urbanski SJ; Swain MG
    Dig Dis Sci; 2001 Sep; 46(9):2043-7. PubMed ID: 11575461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First case of IgG4-related sclerosing cholangitis associated with autoimmune hemolytic anemia.
    Masutani H; Okuwaki K; Kida M; Yamauchi H; Imaizumi H; Miyazawa S; Iwai T; Takezawa M; Koizumi W
    World J Gastroenterol; 2014 Jul; 20(26):8740-4. PubMed ID: 25024635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports.
    Yacoub H; Ben Azouz S; Hassine H; Debbabi H; Cherif D; Ghayeb F; Boukriba S; Kchir H; Maamouri N
    J Med Case Rep; 2023 Apr; 17(1):169. PubMed ID: 37106413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis.
    Franco J; Saeian K
    Curr Gastroenterol Rep; 1999 Apr; 1(2):95-101. PubMed ID: 10980934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune liver diseases and their overlap syndromes].
    Strassburg CP
    Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variant and Specific Forms of Autoimmune Cholestatic Liver Diseases.
    Dalekos GN; Gatselis NK
    Arch Immunol Ther Exp (Warsz); 2019 Aug; 67(4):197-211. PubMed ID: 31165900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical observation of isolated immunoglobulin G4-related sclerosing cholangitis and immunoglobulin G4 sclerosing cholangitis combined autoimmune pancreatitis].
    Jiang P; Lian M; Li B; Xiao X; Miao Q; Wang QX; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):415-419. PubMed ID: 30317753
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary biliary cholangitis associated with warm autoimmune hemolytic anemia.
    Gonzalez-Moreno EI; Martinez-Cabriales SA; Cruz-Moreno MA; Borjas-Almaguer OD; Cortez-Hernandez CA; Bosques-Padilla FJ; Garza AA; Gonzalez-Gonzalez JA; Garcia-Compean D; Ocampo-Candiani J; Maldonado-Garza HJ
    J Dig Dis; 2016 Feb; 17(2):128-31. PubMed ID: 26630456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG4-Related Sclerosing Cholangitis.
    Nakazawa T; Shimizu S; Naitoh I
    Semin Liver Dis; 2016 Aug; 36(3):216-28. PubMed ID: 27466792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Thoughts on Immunoglobulin G4-Related Sclerosing Cholangitis.
    Smit WL; Culver EL; Chapman RW
    Clin Liver Dis; 2016 Feb; 20(1):47-65. PubMed ID: 26593290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of autoimmune hepatic diseases].
    Bueverov AO
    Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of autoimmunity in patients with cholestatic liver diseases.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):73-91. PubMed ID: 26523975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A contribution to the differential diagnostics of sclerosing cholangitides].
    Blaho M; Dítě P; Bojková M; Rydlo M; Kupka T; Svoboda P; Klvaňa P; Martínek A
    Vnitr Lek; 2017; 63(1):50-55. PubMed ID: 28225291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
    Rust C; Beuers U
    Clin Rev Allergy Immunol; 2005 Apr; 28(2):135-45. PubMed ID: 15879619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppression caused by ursodeoxycholic acid].
    Töx U; Theilmann L; Stiehl A
    Z Gastroenterol; 1994 Aug; 32(8):470-1. PubMed ID: 7975791
    [No Abstract]   [Full Text] [Related]  

  • 20. The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis.
    Floreani A; Motta R; Cazzagon N; Franceschet I; Roncalli M; Del Ross T; Rosina F; Lleo A; Mescoli C; Colloredo G; Invernizzi P
    Dig Liver Dis; 2015 May; 47(5):432-5. PubMed ID: 25747115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.